Twitter LinkedIn
    Saturday, February 4
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»IPO»Roivant Sciences Strikes SPAC Deal Valuing The Drug Company At $7.3 Billion
    IPO

    Roivant Sciences Strikes SPAC Deal Valuing The Drug Company At $7.3 Billion

    May 3, 20211 Min Read
    LinkedIn Facebook Twitter Email WhatsApp
    PHILADELPHIA, PA - OCTOBER 05: Vivek Ramaswamy, Founder & CEO of Rolvant Sciences speaks at Forbes Under 30 Summit at Pennsylvania Convention Center on October 5, 2015 in Philadelphia, Pennsylvania. (Photo by Lisa Lake/Getty Images)
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Seven years ago, Vivek Ramaswamy created Roivant Sciences with the aim of finding a new financial model for drug development. On Monday, Roivant Sciences announced it would be going public by merging with a special acquisition company in a deal that values Roivant at $7.3 billion.

    Montes Archimedes Acquisition Corp., a special acquisition company sponsored by Jim Momtazee’s Patient Square Capital, has agreed to merge with Roivant in a transaction that includes a private financing, in which Palantir Technologies, Viking Global Investors, Softbank and others will invest $200 million in the publicly traded equity.

    The transactions are expected to close in the third quarter of 2021 and will provide $611 million in fresh cash for Roivant’s drug development activities, pushing up Roivant’s net cash position to $2.3 billion.

    Matthew Gline, CEO of Roivant, said in an interview the company had explored going public in a traditional initial public offering, but found merging with the Montes Archimedes SPAC a more attractive way to list its shares.

    Read more

    Source: Forbes

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Capital deals and transactions Investments IPO SPAC
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Euroclear moves into $9.8 trillion private asset market with Goji buy

    December 21, 2022

    CAI raises over $1B for inaugural fund and co-investment programme

    November 18, 2022

    KKR looking to sell Canadian gas producer Westbrick for $1.13B

    November 18, 2022

    Blackstone commits up to $359m to acquire majority stake in R Systems

    November 17, 2022

    Comments are closed.

    Other Articles

    Gamut Capital Management and BCI to Invest in PS Logistics

    June 28, 2021

    Odore raises USD830k to transform beauty marketing

    April 24, 2021

    Crown Resorts receives $8b takeover bid from private equity group

    March 22, 2021

    Global investors value China’s Ant Group at over $200 billion

    March 16, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?